Skip to main content

Treatment/Management

Treatment/Management

UCD Management

TREATMENT / MANAGEMENT INFORMATION
Please contact NUCDF for individualized information and support

 New England Consortium of Metabolic Programs Acute Illness Guidelines for Health Professionals

LABORATORY/GENETIC TESTING

 Ravicti or Buphenyl (sodium phenylbutyrate) assay/blood level - an assay to measure levels of phenylacetate/phenylacetylglutamine in patients undergoing Ravicti or Buphenyl drug therapy. This blood test measures these analytes of the drugs, which is useful in determining whether the drugs are being properly metabolized by the body. This information can ultimately assist the patient’s metabolic physician in determining optimal dosing of Ravicti or Buphenyl and avoid the  possibility of underdosing/overdosing, either of which could result in metabolic instability and hyperammonemia. 

 

MENU CLOSE